Literature DB >> 11558063

[Fulminant course of leptospirosis complicated by multiple organ failure].

G I Kirchner1, N Krug, J S Bleck, D Fliser, M P Manns, S Wagner.   

Abstract

We describe a case of a 39-year-old male, who initially presented with severe muscle pain, fever, shortness of breath and tachycardia. He was admitted to hospital with suspected myocarditis. The next days he developed a generalized icterus and acute renal failure. Suspecting leptospirosis an intravenous therapy with penicillin was started. Due to pulmonary and circulatory insufficiency intensive care was necessary. In course the patient developed all known manifestations of leptospirosis including, cardiac arrhythmia and asystolia due to AV-block III degrees, recurrent atelectases of the lungs, hyperbilirubinemia, thrombocytopenia, hepatitis, pancreatitis, very severe rhabdomyolysis and polyradiculitis with areflexia and tetraplegia. Additionally, the patient had a transient hyperthyreosis, which has not been described in the literature so far. After 33 days the patient left the intensive care unit and was discharged out of hospital a fortnight later. 4 weeks later he was able to return to work. The only residuum of this illness is a partial paresis of his right quadriceps muscle.

Entities:  

Mesh:

Year:  2001        PMID: 11558063     DOI: 10.1055/s-2001-16692

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  3 in total

1.  [Severe febrile illness with renal impairment after travel to Southeast Asia].

Authors:  M Seilmaier; W Guggemos
Journal:  Internist (Berl)       Date:  2008-11       Impact factor: 0.743

2.  Severe acute pancreatitis - a serious complication of leptospirosis.

Authors:  D Popa; D Vasile; A Ilco
Journal:  J Med Life       Date:  2013-09-25

3.  Fulminant hepatic failure and acute renal failure as manifestations of concurrent Q fever and cytomegalovirus infection: a case report.

Authors:  Jin-Yi Hsu; Chen-Chi Tsai; Kuo-Chih Tseng
Journal:  BMC Infect Dis       Date:  2014-12-09       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.